Moistening agents for the treatment of chronic dermatoses

Khlebnikova A.N.

doi:https://doi.org/

References:

Ernandes E., Margolina A., Petrukhina A. Lipidnyi bar'er kozhi i kosmeticheskie sredstva. Kosmetika i meditsina 2005; 6: 35-38.
Madison K.S. Barrier function of the skin: "la raison d'etre" of the epidermis. J Invest Dermatol 2003; 121: 231-241.
Menon G.K., Freinfold K.R., Elias P.M. The lamellar secretory response to barrier disruption. J Invest Dermatol 1992; 98: 279-289.
Buxton R.S., Cowin P., Franke W.W. et al. Nomenclature of the desmosomal cadherins. J Cell Biol 1993; 121: 481-483.
Suzuki Y., Nomura J., Koyama J., Horri I. The role of proteases in stratum corneum: involvement in stratum corneum desquamation. Arch Dermatol Res 1994; 286: 369-375.
Egulrud T., Lundstrom A. A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch Dermatol 1991; 283: 108-112.
Chavanas S., Bodemer C., Rochat A. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-142.
Goldstein A.M., Abramovits W. Ceramides and the stratum corneum: structure, function, and new methods to promote repair. Int J Dermatol 2003; 42: 256-259.
Elias P.M., Feingold K.R. Lipids and the epidermal water barrier: metabolism,regulation and pathophysiology. Semin Dermatol 1992; 11: 2: 176-182.
Fulmer A.W., Kramer G.J. Stratum corneum lipid abnormalities in surfactant-induced dry scaly skin. J Invest Dermatol 1986; 86: 5: 598-602.
Serge J.A. Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006; 116: 1150-1158.
Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003; 112: 252-262.
Palmer C.N.A. et al. Common loss-of-funtion variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 10: 1038-1041.
Vasilopoulous Y., Cork M.J., Murphy R. et al. Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62-66.
Kato A., Fukai K., Oiso N. et al. Assotiation of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003; 148: 665-669.
Cork M.G., Robinson D.A., Vasilopoulos Y. et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol 2006; 118: 3-21.
Hara J., Higuchi K., Okamoto R. et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115: 406-413.
Eberlein-Konig B., Schafer T., Huss-Marp J. et al. Skin surface pH, stratum corneum hydration, transepidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 2000; 80: 188-119.
Ghadially R., Reed J.T., Elias P.M. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558-564.
Capon F. et al. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 2001; 116: 728-730.
Zenz R. et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; 437: 369-375.
Lew B.L., Cho Y., Kim J. et al. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK. J Korean Med Sci 2006; 21: 95-99.
Motta S., Monti M., Sesana S. et al. Ceramide composition of the psoriatic scale. Biochim Biophys Acta1993; 1182: 147-151.
Smith F.G., Irvine A.D., Terron-Kwiatkowski A. et al. Loss-of-functionmutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-342.
Richard G. Molecular genetics of the ichthyoses. Am J Med Genet 2004; 131C: 32-44.
Huber M. et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995; 267: 525-528.
Russell J.J. et al. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995; 9: 279-283.
Kuklin V.T., Petrov S.V., Kuklina Z.V. Morfologicheskie izmeneniya v kozhe pri bolezni Deverzhi. Ros zhurn kozh ven bol 2001; 3: 25-27.
Esche C., de Benedetto A., Beck L.A. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 2004; 4: 276-284.
Monakhov K.N., Ochelenko S.A. Primenenie uvlazhnyayushchikh sredstv pri narushenii kozhnogo bar'era. Klin dermatol i venerol 2009; 1: 74-77.
Kucharekova J., Schalkwijk J.K., Van De Kerkhof P.C.M. et al. Effects of lipid-rich emollient containing ceramid 3 in experimentally induced skin barrier dysfunction. Contact Dermat 2002; 46: 331-338.
Berardesca E., Barbareschi M., Veraldi S., Pimpinelli N. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis 2001; 45: 280-285.
Kucharekova M., Van De Kerkhof P.C., Van Der Valk P.G. A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact Dermatitis 2003; 48: 293-299.
Elisyutina O.G., Lapshin N.M., Filimonova T.M. i dr. Vozmozhnosti sovremennykh uvlazhnyayushchikh preparatov v vosstanovlenii funktsii kozhnogo bar'era u bol'nykh atopicheskim dermatitom. Ros allergol zhurn 2009; 4: 75-81.
Korotkii N.G., Tikhomirov A.A., Gamayunov B.N. Krem Lokobeiz Ripea v naruzhnoi terapii atopicheskogo dermatita u detei. Vopr prakt pediatr 2009; 4: 77-81.
Takagi H., Maeda M., Yoneda K. et al. Clinical Evaluation of Efficacy of Locobase REPAIR for Treatment of Atopic Dermatitis and Asteatotic Eczema in Children. J Skin Res 2004; 3: 306-315.
Kawashima M., Mizuno A. Usefulness of Locobase REPAIR for the treatment of dry skin found in atopic and Xeroderma. J Skin Res 2002; 1: 338-346.